{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:04:32Z","timestamp":1790111072675,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05135-1","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:26:15Z","timestamp":1789813575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal care readiness and gaps in early detection of sickle cell nephropathy in children in North Kivu Province, Democratic Republic of the Congo: an exploratory cross-sectional study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2035-7165","authenticated-orcid":false,"given":"Mupenzi","family":"Mumbere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahindo Kangitsi","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kambale Malengera","family":"Victor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lwanzo Sindikubyo","family":"Zaccharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuva Mbahweka","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsongo Kibendelelwa","family":"Zaccharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"5135_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/JBM.S406196","volume":"14","author":"OP Adigwe","year":"2023","unstructured":"Adigwe OP, Onoja SO, Onavbavba G. A Critical Review of Sickle Cell Disease Burden and Challenges in Sub-Saharan Africa. J Blood Med. 2023;14:367.","journal-title":"J Blood Med"},{"key":"5135_CR2","unstructured":"Aeddula NR, Bardhan M, Baradhi KM. Sickle cell nephropathy. StatPearls Publishing. 2023 Sep 4."},{"issue":"23","key":"5135_CR3","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","volume":"3","author":"RI Liem","year":"2019","unstructured":"Liem RI, Lanzkron S, Coates TD, DeCastro L, Desai AA, Ataga KI, et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3(23):3867\u201397.","journal-title":"Blood Adv"},{"key":"5135_CR4","unstructured":"Evidence-Based Management of Sickle Cell Disease. Expert Panel Report, 2014 NHLBI, NIH. https:\/\/www.nhlbi.nih.gov\/resources\/evidence-based-management-sickle-cell-disease-expert-panel-report-2014. Accessed 16 Apr 2026."},{"key":"5135_CR5","doi-asserted-by":"crossref","unstructured":"Abbasi M, Srivastava A, Saraf SL. Management of kidney disease with sickle cell disease. J Am Soc Nephrol. 2025 Oct 1.","DOI":"10.1681\/ASN.0000000804"},{"issue":"2","key":"5135_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1053\/j.ackd.2022.03.004","volume":"29","author":"P Amarapurkar","year":"2022","unstructured":"Amarapurkar P, Roberts L, Navarrete J, El Rassi F. Sickle Cell Disease and Kidney. Adv Chronic Kidney Dis. 2022;29(2):141\u2013e1481.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"5135_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/tropicalmed5030127","volume":"5","author":"BM Mbiya","year":"2020","unstructured":"Mbiya BM, Disashi GT, Gulbis B. Sickle Cell Disease in the Democratic Republic of Congo: Assessing Physicians\u2019 Knowledge and Practices. Trop Med Infect Dis. 2020;5(3):127.","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"5135_CR8","first-page":"199","volume":"26","author":"P Kambale-Kombi","year":"2021","unstructured":"Kambale-Kombi P, Marini Djang\u2019eing\u2019a R, Alworong\u2019a Opara JP, Minon JM, Boemer F, Bours V, et al. Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. Hematol (United Kingdom). 2021;26(1):199\u2013205.","journal-title":"Hematol (United Kingdom)"},{"key":"5135_CR9","doi-asserted-by":"crossref","unstructured":"Munung NS, Raphunga V, Mashalaba A, Nguweneza A, Banda K, Paintsil V, et al. Barriers to sickle cell disease care: a biopsychosocial analysis mapped to the standards of care guidelines by the sickle pan African research consortium. J Public Health (Bangkok). 2025 Nov 27.","DOI":"10.1093\/pubmed\/fdaf147"},{"issue":"12","key":"5135_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/tropicalmed9120292","volume":"9","author":"HW Musuka","year":"2024","unstructured":"Musuka HW, Iradukunda PG, Mano O, Saramba E, Gashema P, Moyo E, Dzinamarira T. Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review. Trop Med Infect Dis. 2024;9(12):292.","journal-title":"Trop Med Infect Dis"},{"key":"5135_CR11","doi-asserted-by":"crossref","unstructured":"Kambale-Kombi P, Marini Djang\u2019eing\u2019a R, Alworong\u2019a, Opara JP, Tonen-Wolyec S, Kayembe Tshilumba C, Batina-Agasa S. Students\u2019 knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo. Hematology. 2020;25(1):91\u20134.","DOI":"10.1080\/16078454.2020.1727174"},{"issue":"1","key":"5135_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12913-025-12330-7","volume":"25","author":"NM Nangunia","year":"2025","unstructured":"Nangunia NM, Mukuku O, Feza VB, Kyembwa YM, Kabesha TB, Mutombo AK, Wembonyama SO. Assessment of healthcare workers\u2019 knowledge and availability of resources for sickle cell disease management in Bukavu, Democratic Republic of the Congo. BMC Health Serv Res. 2025;25(1):164.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"5135_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0253717620946111","volume":"42","author":"C Andrade","year":"2020","unstructured":"Andrade C, Menon V, Ameen S, Kumar Praharaj S. Designing and Conducting Knowledge, Attitude, and Practice Surveys in Psychiatry: Practical Guidance. Indian J Psychol Med. 2020;42(5):478.","journal-title":"Indian J Psychol Med"},{"issue":"7","key":"5135_CR14","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.31557\/APJCP.2024.25.7.2573","volume":"25","author":"F Zarei","year":"2024","unstructured":"Zarei F, Dehghani A, Ratanasiri A, Ghaffari M, Raina SK, Halimi A, et al. ChecKAP: A Checklist for Reporting a Knowledge, Attitude, and Practice (KAP) Study. Asian Pac J Cancer Prev. 2024;25(7):2573.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"5135_CR15","first-page":"241","volume":"5","author":"JA Dennis-Antwi","year":"2008","unstructured":"Dennis-Antwi JA, Dyson SM, Ohene-Frempong K. Healthcare provision for sickle cell disease in Ghana: challenges for the African context. Divers Health Social Care. 2008;5(4):241\u201354.","journal-title":"Divers Health Social Care"},{"key":"5135_CR16","doi-asserted-by":"crossref","unstructured":"Ngonde ACM, Fina JPL, Burgueno E, Lukanu PN. Knowledge and practices of sickle cell disease among healthcare providers in Kinshasa, Democratic Republic of the Congo. Afr J Prim Health Care Fam Med. 2023;16(1).","DOI":"10.4102\/PHCFM.v16i1.3631"},{"issue":"4","key":"5135_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/BS9.0000000000000056","volume":"2","author":"A Sanyaolu","year":"2020","unstructured":"Sanyaolu A, Agiri E, Bertram C, Brookes L, Choudhury J, Datt D, et al. Current modalities of sickle cell disease management. Blood Sci. 2020;2(4):109.","journal-title":"Blood Sci"},{"issue":"6","key":"5135_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-022-00540-9","volume":"18","author":"KI Ataga","year":"2022","unstructured":"Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol. 2022;18(6):361\u201377.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5135_CR19","doi-asserted-by":"publisher","first-page":"106091","DOI":"10.1016\/j.htct.2025.106091","volume":"48","author":"EC Chibuife","year":"2026","unstructured":"Chibuife EC, Adaobi NEC, Jenny CU, Chioma OH, Okwudili AI, Paul OE, et al. Integrating comprehensive care in the management of sickle cell disease patients in Nigeria. Hematol Transfus Cell Ther. 2026;48(1):106091.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"7","key":"5135_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ekir.2020.04.003","volume":"5","author":"G Igiraneza","year":"2020","unstructured":"Igiraneza G, Dusabejambo V, Finklestein FO, Rastegar A. Challenges in the Recognition and Management of Acute Kidney Injury by Hospitals in Resource-Limited Settings. Kidney Int Rep. 2020;5(7):991.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"5135_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12882-020-01731-x","volume":"21","author":"EP Neale","year":"2020","unstructured":"Neale EP, Middleton J, Lambert K. Barriers and enablers to detection and management of chronic kidney disease in primary healthcare: a systematic review. BMC Nephrol. 2020;21(1):83.","journal-title":"BMC Nephrol"},{"issue":"5","key":"5135_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/03630269.2016.1224766","volume":"40","author":"SLH Yeruva","year":"2016","unstructured":"Yeruva SLH, Paul Y, Oneal P, Nouraie M. Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay. Hemoglobin. 2016;40(5):295.","journal-title":"Hemoglobin"},{"issue":"4","key":"5135_CR23","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4):S117\u2013314.","journal-title":"Kidney Int"},{"issue":"11","key":"5135_CR24","doi-asserted-by":"publisher","first-page":"e050880","DOI":"10.1136\/bmjopen-2021-050880","volume":"11","author":"MP Smeltzer","year":"2021","unstructured":"Smeltzer MP, Howell KE, Treadwell M, Preiss L, King AA, Glassberg JA, et al. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA. BMJ Open. 2021;11(11):e050880.","journal-title":"BMJ Open"},{"issue":"5","key":"5135_CR25","doi-asserted-by":"publisher","first-page":"e0216414","DOI":"10.1371\/journal.pone.0216414","volume":"14","author":"RV Masese","year":"2019","unstructured":"Masese RV, Bulgin D, Douglas C, Shah N, Tanabe P. Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers\u2019 perspective. PLoS ONE. 2019;14(5):e0216414.","journal-title":"PLoS ONE"},{"key":"5135_CR26","doi-asserted-by":"crossref","unstructured":"Inusa BPD, Mariachiara L, Giovanni P, Ataga IK, Sickle cell nephropathy: current understanding of the presentation, diagnostic and therapeutic challenges. Hematol Latest Res Clin Adv. 2018 Jun 27.","DOI":"10.5772\/intechopen.76588"},{"issue":"3","key":"5135_CR27","doi-asserted-by":"publisher","first-page":"e057623","DOI":"10.1136\/bmjopen-2021-057623","volume":"12","author":"NM Archer","year":"2022","unstructured":"Archer NM, Inusa B, Makani J, Nkya S, Tshilolo L, Tubman VN, et al. Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ Open. 2022;12(3):e057623.","journal-title":"BMJ Open"},{"issue":"4","key":"5135_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/hemato2040048","volume":"2","author":"M Kilonzi","year":"2021","unstructured":"Kilonzi M, Mlyuka HJ, Felician FF, Mwakawanga DL, Chirande L, Myemba DT, Sambayi G, Mutagonda RF, Mikomangwa WP, Ndunguru J, Jonathan A, Ruggajo P, Minja IK, Balandya E, Makani J, Sirili N. Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania. Hemato. 2021;2(4):713\u201326.","journal-title":"Hemato"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05135-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:03:07Z","timestamp":1790107387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05135-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05135-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8630909\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the \u201cComit\u00e9 d\u2019Ethique du Nord-Kivu\u201d (CENK) (approval reference number: N\u00b0 50\/CENK\/2025). The study was conducted in accordance with the principles of the Declaration of Helsinki. Participation was voluntary, and electronic informed consent was obtained from all participants prior to questionnaire completion.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MM is a pediatrician with a research interest in sickle cell disease, pediatric nephrology, and health system strengthening in resource-limited settings.","order":3,"name":"Ethics","label":"Authors\u2019 information (optional)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"558"}}